Pfizer offers AU$100 million for Australian company that developed COVID-19 cough diagnostic app
Recurrent neural network models (CovRNN) for predicting outcomes of patients with COVID-19 on admission to hospital: model development and validation using electronic health record data
26/04/2022
Israel’s Formula For Combating The Pandemic: Digitalization
02/05/2022
The proposed acquisition and research partnership will add to the biopharmaceutical giant’s growing digital capabilities and bolster its efforts “to pave a new era for digital health”.
Lire l’article complet sur : www.mobihealthnews.com
